| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―15 |
Development of a Novel Indirect ELISA Assay for the Detection of SARS-CoV-2 IgG antibodies using a Highly sensitive RBD-Nucleoprotein Fusion Antigen |
Sohrab - Sam, Behrokh - Farahmand, Hamideh Ofoghi |
| 2 |
[GO] |
2026―May―31 |
Effectiveness of COVID-19 Vaccines in Mahabad, Iran: A Cohort Study |
Nasrin Parsa, Shaker Salarilak, Heidari Mohammad |
| 3 |
[GO] |
2026―May―31 |
Double Jeopardy: The Intersection of COVID-19 and Pregnancy in an Educational Hospital, Northern Iran, Gorgan |
Seyedeh Delafruz Hosseini, Mahdis Banaee, Mohammad Yasaghi, Mostafa Rastegar, Mina Hassanpour, Elham Kashani, et al. (+3) Zahra Sabzi, Piet Cools, Alijan Tabarraei |
| 4 |
[GO] |
2026―May―31 |
COVID-19 and ACE2 receptor in different tissues: From pathophysiologic function to therapeutic responses |
Mohammad Karimian, Mohaddeseh Behjati, Amir Hossein Mohammadi |
| 5 |
[GO] |
2025―Aug―13 |
Diagnosis of latent strongyloidiasis following Corticosteroid Therapy in a Patient with COVID-19 infection |
|
| 6 |
[GO] |
2025―Aug―13 |
Knowledge, Attitude, and Practices regarding COVID-19 (Coronavirus) Infection Control and Prevention among Radiology Staff; a perspective from largest private tertiary care Hospital in Pakistan |
|
| 7 |
[GO] |
2025―Aug―12 |
Severity of COVID-19 infection correlation with IL-17 polymorphism |
|
| 8 |
[GO] |
2025―Jun―29 |
Serological Studies of IgG and IgM in Response to SARS-CoV-2 Vaccination in Erbil, Kurdistan-Iraq |
|
| 9 |
[GO] |
2025―Jun―28 |
The study of mutations and phylogenetics of the SARS-CoV-2 spike gene in population from Tehran province |
|
| 10 |
[GO] |
2025―Jun―28 |
Development of an ELISA for SARS-CoV-2 Detection focusing on antibodies against nucleocapsid protein |
|
| 11 |
[GO] |
2025―Jun―28 |
Unleashing Monoclonal Antibodies: Targeting Covid-19’s Nucleocapsid Protein and Spike Antigens |
|
| 12 |
[GO] |
2025―Jun―28 |
Screening of biofilm-producing genes from Acinetobacter isolates obtained Covid-19 patients in ICU hospital section |
|
| 13 |
[GO] |
2025―Mar―09 |
Safflower-derived cationic lipid nanoparticles: potential impact on the delivery of SARS-CoV-2 mRNA transcripts |
|
| 14 |
[GO] |
2025―Mar―09 |
Assessment of COVID-19 vaccine knowledge, attitude and practice among the general population in Duhok Province, Kurdistan Region of Iraq: A retrospective cross-sectional study |
|
| 15 |
[GO] |
2025―Mar―08 |
A concise review of major challenges in the vaccination, diagnosis and treatment of novel coronavirus disease 2019 |
|
| 16 |
[GO] |
2024―Dec―01 |
COVID-19 Vaccination Adverse Events in Children: An observational Investigation with a Control Group in Tabriz Metropolitan City |
|
| 17 |
[GO] |
2024―Dec―01 |
Effectiveness of vaccination (Sinopharm) among Covid-19 positive patients in a tertiary care hospital |
|
| 18 |
[GO] |
2024―Dec―01 |
Impact of COVID-19 on Treatment in Patients with Renal Cell Carcinoma |
|
| 19 |
[GO] |
2024―Nov―30 |
COVID-19 Vaccine hesitancy among Medical Students of North Delhi |
|
| 20 |
[GO] |
2024―Sep―14 |
Assessment of Serum Levels of Vitamin D and Selected Biochemical and Hematological Parameters in Rats Post-Immunized with Inactivated COVID-19 Virus |
|
| 21 |
[GO] |
2024―Aug―26 |
Use of Tranexamic Acid in SARS-COV-2: Boon or Bane? |
|
| 22 |
[GO] |
2024―Aug―10 |
The predictors of the willingness to receive the third dose of Covid-19 vaccine based on the Health Belief Model: A cross-sectional study in South Khorasan province |
|
| 23 |
[GO] |
2024―Aug―06 |
Pro- or anti-inflammatory properties of cytokines in COVID-19: which offer better protection against disease |
|
| 24 |
[GO] |
2024―Apr―20 |
Investigating of the side effects of covid-19 vaccines in Southern Iran: a cross-sectional study |
|
| 25 |
[GO] |
2024―Apr―07 |
Covid-19 Vaccination Hesitancy among General Population: A Gender based Review and Bibliometric Analysis |
|
| 26 |
[GO] |
2024―Feb―03 |
Correlation of the COVID-19 Infection and Outcomes with Workload among Emergency Healthcare Workers in an Iranian Referral Hospital |
|
| 27 |
[GO] |
2023―Sep―10 |
Impact of ABO Blood Group, Hematological, and Biochemical Abnormalities on Incidence of Patients Infected with COVID-19 |
|